Cholesterol Modified Oligonucleotides
Cholesterol Modified Oligonucleotides - Related Videos
05:33
Using Modified Synthetic Oligonucleotides to Assay Nucleic Acid-Metabolizing Enzymes
0 Views •
Cited by 1 •
2024
Here, a protocol for assaying nucleic acid metabolizing enzymes is presented, using examples of ligase, nuclease, and polymerase enzymes. The assay utilizes fluorescently labeled and unlabeled oligonucleotides that can be combined to form duplexes mimicking RNA and/or DNA damages or pathway intermediates, allowing for the characterization of enzyme behavior.
07:25
Transfection and Mutagenesis of Target Genes in Mosquito Cells by Locked Nucleic Acid-modified Oligonucleotides
0 Views •
Cited by 3 •
2010
Oligonucleotides can be used to site specifically substitute a single nucleotide of transfected target genes in both Anopheles gambiae and Anopheles stephensi cells.
11:07
Macrophage Cholesterol Depletion and Its Effect on the Phagocytosis of Cryptococcus neoformans
0 Views •
Cited by 21 •
2014
In this article, a protocol for infection of macrophages with Cryptococcus neoformans is described. Also, a method for sterol depletion from the macrophages is explained. These protocols provide a guide to study fungal infections in vitro and examine the role of sterols in such infections.
13:19
Chemical Triphosphorylation of Oligonucleotides
0 Views •
Cited by 1 •
2022
Oligonucleotide 5′-triphosphates are ubiquitous components in essential biological pathways and have seen increasing use in biotechnology applications. Here, we describe techniques for the routine synthesis and purification of oligonucleotide 5′-triphosphates, starting from oligonucleotides prepared by standard automated synthesis techniques.
01:29
Cholesterol: Significance and Regulation
0 Views •
2024
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces. Considering cholesterol and...
FAQs
The cholesterol group contributes a hydrophobic domain, while the nucleic-acid strand remains the sequence-directed component. Together, these features give the conjugate amphiphilic behavior, allowing it to associate with lipid membranes rather than behaving only according to the properties of the unmodified strand. This interaction can influence molecular localization and movement through biological systems.
Covalent attachment links the cholesterol group directly to the DNA or RNA strand, creating a single conjugate with altered physicochemical properties. The modification can affect membrane association, cellular uptake, transport, distribution, localization, and stability while preserving the strand’s sequence-specific interaction with nucleic acid targets. This combination connects delivery-related behavior with gene-regulating function.
Membrane association can help position or transport the conjugate within a biological system, whereas sequence-specific binding determines which nucleic acid target the oligonucleotide can recognize. These functions address different requirements: the cholesterol modification influences access and distribution, while the nucleotide sequence supplies molecular selectivity. Effective bioengineering designs therefore consider both properties together.
The approach can support antisense oligonucleotides, small interfering RNAs, and other gene-regulating molecules. These cargos use sequence-dependent interactions to influence nucleic acid targets, while the cholesterol group contributes membrane-related behavior. Selecting among these formats allows bioengineers to explore different molecular tools for gene regulation, depending on whether the goal involves antisense activity, RNA interference, or another strategy.
Bioengineers use these conjugates to design and study nucleic-acid tools whose distribution and cellular behavior may be improved through cholesterol-mediated membrane interactions. Research applications include gene silencing, molecular diagnostics, and therapeutic development. The same modification therefore serves both as a delivery-oriented design feature and as a way to investigate how oligonucleotide properties affect biological performance.
Evaluation can focus on cellular uptake, transport, distribution, localization, and stability, alongside the oligonucleotide’s sequence-specific activity. These outcomes show whether the cholesterol modification changes how the molecule behaves in a biological system without eliminating its targeting function. Such information helps researchers refine conjugates for gene silencing studies, diagnostic designs, and therapeutic development.